Skip to main content
. 2014 Jan 24;9(1):e87049. doi: 10.1371/journal.pone.0087049

Table 4. Combination analysis of the IFN-γ SNPs and sepsis development by clinical grouping.

Sepsis(%) Severesepsis (%) OR(95%CL) Pvalue APACHE < = 20 (%) APACHE >20 (%) OR(95%CL) Pvalue SOFA < = 10 (%) SOFA >10 (%) OR(95%CL) Pvalue Discharged (%) Death(%) OR(95%CL) P value
−1616 T/C
CC 36 (40.5) 47 (43.9) 1.00 (reference) 41 (44.1) 42 (41.2) 1.00 (reference) 45 (43.3) 38 (41.3) 1.00 (reference) 41 (37.6) 42 (48.3%) 1.00 (reference)
TC 39 (43.8) 59 (55.1) 1.25 (0.67–2.34) 38 (40.9) 60 (58.8) 1.65 (0.88–3.10) 45 (43.3) 53 (57.6) 1.39 (0.77–2.54) 60 (55.1) 38 (43.7%) 0.68 (0.37–1.25)
TT 14 (15.7) 1 (0.9) 0.06 (0.01–0.50) <0.001 15 (16) 0 NA <0.0001 14 (13.5) 1 (1.1) 0.09 (0.01–0.75) 0.001 8 (7.3) 7 (8.3) 0.98 (0.31–3.07) 0.44
TC+TT 53 (59.5) 60 (56.1) 0.94 (0.51–1.72) 0.84 53 (56.4) 60 (58.8) 1.18 (0.65–2.16) 0.58 59 (56.7) 54 (58.7) 1.10 (0.61–1.97) 0.75 68 (62.4) 42 (50) 0.72 (0.40–1.29) 0.27
C 111 (62.4) 153 (71.5) 1.00 (reference) 120 (63.8) 144 (70.6) 1.00 (reference) 135 (64.9) 129 (70.1) 1.00 (reference) 142 (65.1) 122 (70.1) 1.00 (reference)
T 67 (37.6) 61 (28.5) 1.51 (0.99–2.31) 0.05 68 (36.2) 60 (29.4) 1.36 (0.89–2.07) 73 (35.1) 55 (29.9) 1.27 (0.83–1.94) 0.27 76 (34.9) 52 (29.9) 1.26 (0.82–1.93) 0.3
+874 A/T
TT 47 (52.8) 69 (64.5) 1.00 (reference) 55 (58.5) 61 (59.8) 1.00 (reference) 62 (59.6) 54 (58.7) 1.00 (reference) 58 (53.2) 58 (66.7) 1.00 (reference)
TA 34 (38.2) 37 (34.6) 0.77 (0.41–1.43) 30 (31.9) 41 (40.2) 1.28 (0.68–2.38) 33 (31.7) 38 (41.3) 1.30 (0.71–2.38) 45 (41.3) 26 (29.9) 0.63 (0.34–1.18)
AA 8 (9) 1 (0.9) 0.19 (0.02–1.66) 0.18 9 (9.6) 0 (0) NA 0.012 9 (8.7) 0 (0) NA 0.005 6 (5.5) 3 (3.4) 1.45 (0.31–6.79) 0.35
TA+AA 42 (47.2) 38 (35.5) 0.70 (0.38–1.29) 0.25 39 (41.5) 41 (40.2) 1.08 (0.59–2.00) 0.8 42 (40.4) 38 (41.3) 1.09 (0.60–1.97) 0.77 51 (46.8) 29 (33.3) 0.65 (0.36–1.19) 0.16
A 50 (28.1) 39 (18.2) 1.00 (reference) 48 (25.5) 41 (20.1) 1.00 (reference) 51 (24.5) 38 (20.7) 1.00 (reference) 57 (26.1) 32 (18.4) 1.00 (reference)
T 128 (71.9) 175 (81.8) 0.57 (0.35–0.91) 0.02 140 (74.5) 163 (79.9) 0.73 (0.46–1.19) 0.2 157 (75.5) 146 (79.3) 0.80 (0.50–1.29) 0.36 161 (73.9) 142 (81.6) 0.64 (0.39–1.04) 0.07
+3234 C/T
TT 48 (53.9) 69 (64.5) 1.00 (reference) 56 (59.6) 61 (59.8) 1.00 (reference) 63 (60.6) 54 (58.7) 1.00 (reference) 59 (54.1) 58 (66.7) 1.00 (reference)
TC 34 (38.2) 37 (34.6) 0.78 (0.42–1.45) 30 (31.9) 41 (40.2) 1.30 (0.70–2.42) 33 (31.7) 38 (41.3) 1.33 (0.73–2.42) 45 (41.3) 26 (29.9) 0.64 (0.35–1.20)
CC 7 (7.9) 1 (0.9) 0.22 (0.02–2.01) 0.27 8 (8.5) 0 (0) NA 0.02 8 (7.7) 0 (0) NA 0.009 5 (4.6) 3 (3.6) 1.07 (0.22–5.15) 0.36
TC+CC 41 (46.1) 38 (35.5) 0.72 (0.39–1.33) 0.3 38 (40.4) 41 (40.2) 1.12 (0.61–2.06) 0.72 41 (39.4) 38 (41.3) 0.79 (0.41–1.51) 0.81 50 (45.9) 29 (33.3) 0.67 (0.37–1.23) 0.20
T 130 (73.0) 175 (81.8) 1.00 (reference) 142 (75.5) 163 (79.9) 1.00 (reference) 159 (76.4) 146 (79.3) 1.00 (reference) 163 (74.8) 142 (81.6) 1.00 (reference)
C 48 (27.0) 39 (18.2) 0.60 (0.37–0.98) 0.04 46 (24.5) 41 (20.1) 0.78 (0.48–1.25) 0.3 49 (23.6) 38 (20.7) 0.84 (0.52–1.36) 0.49 55 (25.2) 32 (18.4) 0.67 (0.41–1.09) 0.11
Haplotype
C T T 111 (61.7) 153 (71.5) 1.51 (0.99–2.31) 0.054 120 (63.2) 144 (70.6) 1.36 (0.89–2.08) 0.154 135 (64.3) 129 (70.1) 1.27 (0.83–1.94) 0.273 139 (63.8) 125 (71.8) 1.32 (0.86–2.04) 0.202
T A C 48 (26.7) 39 (18.2) 0.60 (0.37–0.98) 0.038 46 (24.2) 41 (20.1) 0.78 (0.48–1.25) 0.298 49 (23.3) 38 (20.7) 0.85 (0.52–1.36) 0.489 56 (25.7) 31 (17.8) 0.68 (0.41–1.11) 0.122
T T T 19 (10.6) 22 (10.3) 0.96 (0.50–1.84) 0.899 22 (11.6) 19 (9.3) 0.78 (0.41–1.48) 0.44 24 (11.4) 17 (9.2) 0.78 (0.41–1.50) 0.458 23 (10.5) 18 (10.4) 1.05 (0.55–2.01) 0.886

Values in bold and underline indicate statistical significance.